New medicines agreement aims to tackle chronic supply crisis across bloc with public funding support.
ℹ️ Browser-based reading · AI studio voice coming soon
EU negotiators have reached agreement on new rules designed to address persistent drug shortages that have plagued the European bloc.
The accord includes measures to ease the use of public funds in supporting production of essential medicines, a key mechanism to stabilize supply chains. The agreement reflects growing concern among member states over medication availability across critical therapeutic categories.
The new framework is expected to strengthen pharmaceutical resilience and reduce dependency on external suppliers for vital treatments.
EU negotiators have agreed on new rules to tackle chronic drug shortages, including measures to use public funds to support essential medicine production and stabilize supply chains across the bloc.
If implemented effectively, this framework could reduce delays in accessing critical medications and lower prices by decreasing reliance on external suppliers—directly affecting your ability to get prescribed treatments without delays or inflated costs.